MSF responds to latest WHO recommendation for a COVID-19 therapeutic, baricitinib
Geneva: With the World Health Organization (WHO) recommending baricitinib for the treatment of people with severe or critical COVID-19, Doctors Without Borders/Médecins Sans Frontières (MSF) calls on governments to take immediate steps to ensure that patent monopolies do not stand in the way of access to this treatment. In hospitalised patients, the oral drug baricitinib can … Read more